SCOPUS 정보 검색 플랫폼

Volumn 70, Issue 5, 2000, Pages 717-722

Cytomegalovirus antigenemia directed pre-emptive prophylaxis with oral versus I.V. ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients: A randomized, controlled trial

(5) Singh, Nina a,b Paterson, David L a,b,c Gayowski, Timothy a,b Wagener, Marilyn M a Marino, Ignazio R a,b,c

a VETERANS AFFAIRS MEDICAL CENTER (United States)

b UNIVERSITY OF PITTSBURGH MEDICAL CENTER (United States)

c MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CREATININE; GANCICLOVIR; VIRUS ANTIGEN;

ADULT; ARTICLE; BLOOD CULTURE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG COST; DRUG EFFICACY; FEMALE; HUMAN; INFECTION PREVENTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRUS DETECTION;

EID: 0034666047 PISSN: 00411337 EISSN: None Source Type: Journal
DOI: 10.1097/00007890-200009150-00002 Document Type: Article

Times cited : (88)

References (21)

1
- 0031581506
- Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients
- (1997) Lancet , vol.350 , pp. 1729
- Gane, E.¹ Saliba, F.² Valdecasas, G.J.C.³ O'Grady, J.⁴ Pescovitz, M.D.⁵ Lyman, S.⁶

2
- 0029065431
- Randomized comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver transplant recipients
- (1995) Lancet , vol.346 , pp. 69
- Winston, D.J.¹ Wirin, D.² Shaked, A.³ Busuttil, R.W.⁴

3
- 0029782102
- Cytomegalovirus infection following liver transplantation: Review of the literature
- (1996) Clin Infect Dis , vol.22 , pp. 537
- Kanj, S.S.¹ Sharara, A.I.² Clavien, P.A.³ Hamilton, J.D.⁴

4
- 0032521302
- Preemptive treatment for the prevention of cytomegalovirus disease
- (1998) Transplantation , vol.65 , pp. 747
- Egan, J.J.¹ Lomax, J.² Barber, L.³ Lok, S.S.⁴ Martyszczuk, R.⁵ Yonan, N.⁶

5
- 0028799407
- Preemptive ganciclovir therapy in cytomegalovirus seropositive renal transplant recipients
- (1995) Arch Surg , vol.130 , pp. 1217
- Conti, D.J.¹ Freed, B.M.² Singh, P.³ Gallichio, M.⁴ Gruber, S.A.⁵

6
- 0030900609
- A risk-adapted approach with a short-course of ganciclovir to prevent cytomegalovirus pneumonia in CMV-seropositive recipients of allogeneic bone marrow transplants
- (1997) Clin Infect Dis , vol.24 , pp. 901
- Verdonck, L.F.¹ Dekker, A.W.² Rosenberg-Arska, M.³ Van den Hoek, M.⁴

7
- 0029897418
- Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors
- (1996) Transplantation , vol.61 , pp. 1659
- Grossi, P.¹ Kusne, S.² Rinaldo, C.³ St. George, K.⁴ Magone, M.⁵ Rakela, J.⁶

8
- 0032530706
- Infectious complications occurring in liver transplant recipients receiving mycophenolate mofetil
- (1998) Transplantation , vol.66 , pp. 593
- Paterson, D.L.¹ Singh, N.² Panebianco, A.³ Wannstedt, C.F.⁴ Wagener, M.M.⁵ Gayowski, T.⁶

9
- 0027979240
- High-dose ayclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients: A randomized trial
- (1994) Ann Intern Med , vol.120 , pp. 375
- Singh, N.¹ Yu, V.L.² Mieles, L.³ Wagener, M.M.⁴ Miner, R.C.⁵ Gayowski, T.⁶

10
- 4243670914
- Ganciclovir sodium
- McEvoy GK, eds. American Hospital Formulary Service, Drug Information
- (1999) , pp. 527

11
- 0008074812
- Montvale Medical Economics. Drug Topics Red Book. Montvale Medical Economics Company, Inc.

12
- 4243310854
- Preemptive treatment of CMV infection after liver transplantation using oral ganciclovir: Preliminary results
- (1997) Hepatology , vol.26
- Duvoux, C.¹ Challine-Lehmann, D.² Pawlotsky, J.M.³ Metreau, J.M.⁴ Cherqui, D.⁵ Duval, J.⁶

13
- 0008151815
- Preemptive therapy with oral ganciclovir of cytomegalovirus disease in liver transplant recipients monitorized with plasma PCR and leucocytes viral load. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada 1999; Abstract H59a
- (1999)
- Torre-Cisneros, J.¹ Madueno, J.A.² Gonzalez, R.³ Herrero, C.⁴ Martinez, L.⁵ Gavilan, F.⁶

14
- 0025828334
- Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection
- (1991) J Infect Dis , vol.163 , pp. 716
- Drew, W.L.¹ Miner, R.C.² Busch, D.F.³

15
- 0031037245
- Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation
- (1997) Transplantation , vol.63 , pp. 476
- Rosen, H.R.¹ Brenner, K.G.² Flora, K.D.³ Rabkin, J.M.⁴ Orloff, S.L.⁵ Olyaei, A.⁶

16
- 0031944950
- Rising levels of human cytomegalovirus (HCMV) antigenemia during initial antiviral treatment of solid-organ transplant recipients with primary HCMV infection
- (1998) J Clin Microbiol , vol.36 , pp. 1113
- Gerna, G.¹ Zavattoni, M.² Percivalle, E.³ Grossi, P.⁴ Torsellini, M.⁵ Grazia-Revello, M.⁶

17
- 0008074142
- Increasing CMV antigenemia during preemptive antiviral therapy after allogeneic bone marrow or peripheral blood stem cell transplantation (BMT) is not associated with increased risk for CMV disease (abstract No. 1410). 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 26-29, 1999 (sponsor American Society for Microbiology, Washington, D.C.)
- (1999)
- Nichols, W.G.¹ Corey, L.² Drew, L.³ Gooley, T.⁴ Davis, C.⁵ Boeckh, M.⁶

18
- 0033610462
- Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: A cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients
- (1999) Transplantation , vol.68 , pp. 1125
- Kusne, S.¹ Grossi, P.² Irish, W.³ St. George, K.⁴ Rinaldo, C.⁵ Rakela, J.⁶

19
- 0029027137
- Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: A phase I/II study
- (1995) J Infect Dis , vol.171 , pp. 1431
- Spector, S.A.¹ Busch, D.F.² Follansbee, S.³ Squires, K.⁴ Lalezari, J.P.⁵ Jacobson, M.A.⁶

20
- 0018103242
- Sample size requirements for evaluating a conservative therapy
- (1978) Cancer Treat Rep , vol.62 , pp. 1037
- Makuch, R.¹ Simon, R.²

21
- 0033973173
- Cost-effectiveness of different strategies of cytomegalovirus prophylaxis in orthotopic liver transplant recipients
- (2000) Hepatology , vol.31 , pp. 311
- Das, A.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.